Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children

Trans R Soc Trop Med Hyg. 2010 May;104(5):357-63. doi: 10.1016/j.trstmh.2010.01.009. Epub 2010 Feb 12.

Abstract

A prospective study in three Egyptian villages (A, B and C) having a high prevalence of hepatitis C virus (HCV) infection examined incidence of community-acquired HCV infection in children; 2852 uninfected infants were prospectively followed from birth for up to 5.5 years. Fifteen seroconverted for either HCV antibodies and/or HCV-RNA (incidence of 0.53%). Ten had both anti-HCV and HCV-RNA; four had only anti-HCV; and one had HCV-RNA in the absence of antibody. The incidence rate at all ages was 2.7/1000 person-years (PY). It was 3.8/1000 PY during infancy and 2.0/1000 PY for the 1-5-years age group. Hospitalization and low birth weight increased the risk of infection; while living in village B, the family having a higher socioeconomic status, and advanced maternal education were protective. Six of eight HCV-infected infants reported iatrogenic exposures (e.g. hospitalization, therapeutic injections, ear piercing) prior to infection whereas only 2/7 children older than 1 year reported these exposures. Having an HCV-positive mother was the only other reported risk in two of these older children. The virus cleared in six (40%) children by the end of follow-up. Health education targeting iatrogenic exposures and focusing on risk factors could reduce HCV infection in children in high-risk populations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Piercing / adverse effects
  • Child, Preschool
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / immunology
  • Community-Acquired Infections / transmission
  • Egypt / epidemiology
  • Epidemiologic Methods
  • Female
  • Hepatitis C / epidemiology*
  • Hepatitis C / immunology
  • Hepatitis C / transmission
  • Hepatitis C Antibodies / blood
  • Hospitalization / statistics & numerical data
  • Humans
  • Infant
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Male
  • RNA, Viral / blood
  • Rho(D) Immune Globulin / administration & dosage
  • Rural Population
  • Socioeconomic Factors
  • Transfusion Reaction

Substances

  • Hepatitis C Antibodies
  • RNA, Viral
  • Rho(D) Immune Globulin